The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global digital PCR market reached a value of US$ 3.8 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 7.42 Billion by 2027, exhibiting a CAGR of 11.50% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
Digital polymerase chain reaction, or digital PCR (dPCR), refers to an end-point, high-throughput absolute quantitative analytics that assists in measuring the DNA or RNA count in a given sample in a precise and sensitive way. Designed for absolute quantification and the analysis of minority sequences against a background of similar majority sequences, it is semi-quantitative as the amplified product is detected by agarose gel electrophoresis. When compared to its traditional counterparts, digital PCR uses a wide range of methods, such as droplet-based, chip-based, and beaming dPCR, to facilitate diverse applications. As a result, dPCR methods are extensively utilized in basic and diagnostic research, such as human genetic testing, pathogen detection, infectious disease testing and forensic sciences.
The market is primarily driven by the increasing healthcare expenditure on molecular diagnosis across the globe. This can be attributed to the rising prevalence of numerous diseases, such as genetic disorders, COVID-19, lung cancer, brain tumors, breast cancer and blood cancer. In addition to this, the escalating consumer demand for early diagnosis and treatment has resulted in extensive research and development (R&D) focusing on genetic technologies, which, in turn, is propelling the market. Besides this, continual technological advancements in PCR technologies, along with the launch of innovative devices for droplet, chip-based, beam, and crystal dPCR by major market players, are creating a positive outlook for the market. The market is further driven by the growing adoption of dPCR devices in reference laboratories for detecting genetic mutations and identifying pathogens, thereby leading to a higher product uptake. Some of the other factors that are contributing to the market growth include favorable initiatives undertaken by governmental and federal agencies across the globe, a paradigm shift from plant-derived to genome-based drug discovery, and augmenting product applications in food microbiology and veterinary medicine.
IMARC Group provides an analysis of the key trends in each sub-segment of the global digital PCR market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on product type, technology and application.
Breakup by Product Type:
Breakup by Technology:
Breakup by Application:
Breakup by Region:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Avance Biosciences Inc., Bio-Rad Laboratories Inc., Danaher Corporation, JN Medsys, OPTOLANE Technologies Inc., QIAGEN, SAGA Diagnostics AB, Standard BioTools Inc., Stilla Technologies, Sysmex Corporation and Thermo Fisher Scientific Inc.
|Base Year of the Analysis||2021|
|Segment Coverage||Product Type, Technology, Application, Region|
|Region Covered||Asia Pacific, Europe, North America, Latin America, Middle East and Africa|
|Countries Covered||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico|
|Companies Covered||Avance Biosciences Inc., Bio-Rad Laboratories Inc., Danaher Corporation, JN Medsys, OPTOLANE Technologies Inc., QIAGEN, SAGA Diagnostics AB, Standard BioTools Inc., Stilla Technologies, Sysmex Corporation and Thermo Fisher Scientific Inc.|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at